Edwards Lifesciences
EW
Delayed Nyse - 11/22 10:01:48 pm
108.81USD
-0.65%
Prev.109.5200
Open109.2600
High109.6100
Low108.2600
Volume835 977
Last news
Financials
Sales 2017 3 391 M
EBIT 2017 1 020 M
R. net 2017 789 M
Tréso. 2017 256 M
Rend. 2017 -
P/E ratio 2017 30,20
P/E ratio 2018 26,42
EV / Sales 2017 6,72x
EV / Sales 2018 6,02x
Capitalization 23 026 M
Company
Edwards Lifesciences Corp. engages in the design, development, manufacture, and markets products to treat stage cardiovascular disease.It operates through the following geographical segments: United States, Europe, Japan, and Rest of the World.Its products are categorized into three areas: Surgical...
Sector :
Advanced Medical Equipment & Technology - NEC
Calendar :
2017-12-07 Investor Conference
Trading Rating :
Investor Rating :
Technical analysis trends
Short TermMid-TermLong Term
TrendNeutralBearishBullish
Resistance112112120
Spread/Res.-2,5%-2,5%-9,4%
Spread/Supp.7,3%7,3%7,2%
Support101101102